This company is a pre-seed company focused on the development of microcapillary needles for the microinjection of biological materials into cells. Our novel technologies have numerous advantages in research and biomedical applications including fertility and artificial in-vitro reproduction. Two lines of microcapillary needles SeeTrue Glass, SeeTrue PreCal are currently under different stages of development and are for Research-Use-Only applications in academic, biopharma and government transgenic and biomedical research laboratories. The third line, SeeTrue ART (Artificial Reproductive Technology) is intended for use for fertility treatments and genetic testing in Humans, in fertility and reproductive clinics.